Should I buy or sell Integrated Diagnostics stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Integrated Diagnostics in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" IDGXF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in IDGXF, but not buy additional shares or sell existing shares. View IDGXF analyst ratings or view top-rated stocks .

How have IDGXF shares performed in 2024?

Integrated Diagnostics' stock was trading at $0.3370 at the start of the year. Since then, IDGXF stock has decreased by 12.2% and is now trading at $0.2960. View the best growth stocks for 2024 here .

Are investors shorting Integrated Diagnostics?

Integrated Diagnostics saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 22,300 shares, an increase of 123.0% from the March 15th total of 10,000 shares. Based on an average daily trading volume, of 0 shares, the days-to-cover ratio is currently ∞ days. View Integrated Diagnostics' Short Interest .

How do I buy shares of Integrated Diagnostics?

Shares of IDGXF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:IDGXF

Integrated Diagnostics (IDGXF) Stock Price, News & Analysis

→ It’s now possible to know the win rate of every trade… BEFORE you take it! (From WealthPress) (Ad)

Free IDGXF Stock Alerts

$0.30

0.00 (0.00%)

(As of 04/26/2024 ET)

Compare

Today's Range: $0.30
▼
$0.30
50-Day Range: $0.28
▼
$0.33
52-Week Range: $0.28
▼
$0.58

Volume: N/A
Average Volume: 67,650 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Analyst Forecasts Chart Short Interest

Get Integrated Diagnostics alerts:

Ad Banyan Hill Publishing

Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years

If you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)

Watch my video for all of the details

About Integrated Diagnostics Stock (OTCMKTS:IDGXF)

Integrated Diagnostics Holdings plc, a consumer healthcare company, provides various medical diagnostics services to patients. It offers approximately 3,000 diagnostic pathology tests, such as immunology, microbiology, haematology, endocrinology, clinical chemistry, molecular biology, parasitology, histopathology, and genetics. The company also provides radiology services, including positron emission tomography computed tomography (PET-CT), magnetic resonance imaging (MRI), computed tomography (CT), mammography, ultrasound, x-ray, electromyography (EMG), electroencephalography, electroencephalogram (EEG), and electrocardiogram (ECG), as well as operates cath lab facilities. It operates in Egypt, Sudan, Jordan, Nigeria, and the Kingdom of Saudi Arabia. The company was founded in 1979 and is headquartered in Saint Helier, Jersey.

IDGXF Stock Price History

30 days | 90 days | 365 days | Advanced Chart

IDGXF Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

Receive IDGXF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Integrated Diagnostics and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Diagnostics & Research
Sub-Industry: N/A
Current Symbol: OTCMKTS:IDGXF
CUSIP: N/A
CIK: N/A
Web: www.idhcorp.com
Phone: 44-15-3484-7000
Fax: N/A
Employees: 6,692
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

These 7 Stocks Will Be Magnificent in 2024

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Key Executives

Dr. Hend El Sherbini (Age 55)
Group CEO & Executive Director
Comp: $17.07M
Mr. Sherif Mohamed Mohamed El Zeiny
Group CFO & Executive Director
Dr. Eissa Khorshid
Chief Operating Officer
Nancy Fahmy
Investor Relations Director
Mr. Mohamed Kamel Saleh (Age 42)
General Counsel
Dr. Seham Ibrahim (Age 55)
Sales Director
Comp: $599.24k

Key Competitors

View All Competitors

IDGXF Stock Analysis - Frequently Asked Questions

Should I buy or sell Integrated Diagnostics stock right now?: 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Integrated Diagnostics in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" IDGXF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in IDGXF, but not buy additional shares or sell existing shares.
View IDGXF analyst ratings or view top-rated stocks.
How have IDGXF shares performed in 2024?: Integrated Diagnostics' stock was trading at $0.3370 at the start of the year. Since then, IDGXF stock has decreased by 12.2% and is now trading at $0.2960.
View the best growth stocks for 2024 here.
Are investors shorting Integrated Diagnostics?: Integrated Diagnostics saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 22,300 shares, an increase of 123.0% from the March 15th total of 10,000 shares. Based on an average daily trading volume, of 0 shares, the days-to-cover ratio is currently ∞ days.
View Integrated Diagnostics' Short Interest.
How do I buy shares of Integrated Diagnostics?: Shares of IDGXF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:IDGXF) was last updated on 4/27/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial